As of 2026-09-23, the Relative Valuation of Atara Biotherapeutics Inc (ATRA) is (24.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.56 USD, the upside of Atara Biotherapeutics Inc based on Relative Valuation is -385.6%.
The range of the Relative Valuation is (46.49) - 2.53 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.1x - 29.7x | 27.4x |
| Forward P/E multiples | 30.5x - 65.2x | 47.8x |
| Fair Price | (46.49) - 2.53 | (24.45) |
| Upside | -643.1% - -70.5% | -385.6% |
| Date | P/E |
| 2026-09-18 | -5.23 |
| 2026-09-17 | -5.24 |
| 2026-09-16 | -5.46 |
| 2026-09-15 | -5.10 |
| 2026-09-14 | -4.99 |
| 2026-09-11 | -5.06 |
| 2026-09-10 | -5.34 |
| 2026-09-09 | -5.35 |
| 2026-09-08 | -5.52 |
| 2026-09-04 | -5.27 |
| 2026-09-03 | -5.15 |
| 2026-09-02 | -5.10 |
| 2026-09-01 | -4.87 |
| 2026-08-31 | -4.81 |
| 2026-08-28 | -4.97 |
| 2026-08-27 | -4.99 |
| 2026-08-26 | -5.06 |
| 2026-08-25 | -5.31 |
| 2026-08-24 | -5.11 |
| 2026-08-21 | -5.24 |
| 2026-08-20 | -5.06 |
| 2026-08-19 | -5.18 |
| 2026-08-18 | -4.71 |
| 2026-08-17 | -4.51 |
| 2026-08-14 | -4.37 |
| 2026-08-13 | -4.59 |
| 2026-08-12 | -4.98 |
| 2026-08-11 | -4.83 |
| 2026-08-10 | -4.65 |
| 2026-08-07 | -4.56 |
| 2026-08-06 | -4.45 |
| 2026-08-05 | -4.61 |
| 2026-08-04 | -4.74 |
| 2026-08-03 | -4.62 |
| 2026-07-31 | -4.52 |
| 2026-07-30 | -4.41 |
| 2026-07-29 | -4.35 |
| 2026-07-28 | -4.22 |
| 2026-07-27 | -4.16 |
| 2026-07-24 | -4.27 |
| 2026-07-23 | -4.41 |
| 2026-07-22 | -4.39 |
| 2026-07-21 | -4.66 |
| 2026-07-20 | -4.48 |
| 2026-07-17 | -4.53 |
| 2026-07-16 | -4.71 |
| 2026-07-15 | -4.62 |
| 2026-07-14 | -4.34 |
| 2026-07-13 | -4.68 |
| 2026-07-10 | -5.27 |